Literature DB >> 32147534

Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management.

Matthew D Seftel1, Michelle Kuxhausen2, Linda Burns2, Pintip Chitphakdithai2, Dennis Confer2, Deirdre Kiefer2, Stephanie Lee3, Brent Logan4, Paul O'Donnell5, Michael Pulsipher6, Nirali N Shah7, Galen Switzer8, Bronwen E Shaw9.   

Abstract

Entities:  

Year:  2020        PMID: 32147534      PMCID: PMC7440392          DOI: 10.1016/j.bbmt.2020.02.022

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  8 in total

1.  Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding.

Authors:  Youn K Shim; Jane M Rachel; Paolo Ghia; Jeff Boren; Fatima Abbasi; Antonis Dagklis; Geri Venable; Jiyeon Kang; Heba Degheidy; Fred V Plapp; Robert F Vogt; Jay E Menitove; Gerald E Marti
Journal:  Blood       Date:  2013-12-17       Impact factor: 22.113

2.  Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.

Authors:  Mareike Frick; Willy Chan; Christopher Maximilian Arends; Raphael Hablesreiter; Adriane Halik; Michael Heuser; David Michonneau; Olga Blau; Kaja Hoyer; Friederike Christen; Joel Galan-Sousa; Daniel Noerenberg; Verena Wais; Michael Stadler; Kenichi Yoshida; Johannes Schetelig; Esther Schuler; Felicitas Thol; Emmanuelle Clappier; Maximilian Christopeit; Francis Ayuk; Martin Bornhäuser; Igor Wolfgang Blau; Seishi Ogawa; Tomasz Zemojtel; Armin Gerbitz; Eva M Wagner; Bernd M Spriewald; Hubert Schrezenmeier; Florian Kuchenbauer; Guido Kobbe; Markus Wiesneth; Michael Koldehoff; Gérard Socié; Nicolaus Kroeger; Lars Bullinger; Christian Thiede; Frederik Damm
Journal:  J Clin Oncol       Date:  2018-11-07       Impact factor: 44.544

3.  Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients.

Authors:  Ilaria Del Giudice; Francesca Romana Mauro; Maria Stefania De Propris; Irene Della Starza; Daniele Armiento; Anna Paola Iori; Giovanni Fernando Torelli; Anna Guarini; Robin Foà
Journal:  Blood       Date:  2009-09-24       Impact factor: 22.113

4.  Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy.

Authors:  Katarzyna Rojek; Eric Nickels; Barbara Neistadt; Rafael Marquez; Amittha Wickrema; Andrew Artz; Koen van Besien; Richard A Larson; Ming K Lee; Jeremy P Segal; Mary-Claire King; Tom Walsh; Akiko Shimamura; Sioban B Keel; Jane E Churpek; Lucy A Godley
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-04       Impact factor: 5.742

Review 5.  Can G-CSF cause leukemia in hematopoietic stem cell donors?

Authors:  Belinda R Avalos; Aleksandr Lazaryan; Edward A Copelan
Journal:  Biol Blood Marrow Transplant       Date:  2011-07-13       Impact factor: 5.742

6.  Age-related clonal hematopoiesis associated with adverse outcomes.

Authors:  Siddhartha Jaiswal; Pierre Fontanillas; Jason Flannick; Alisa Manning; Peter V Grauman; Brenton G Mar; R Coleman Lindsley; Craig H Mermel; Noel Burtt; Alejandro Chavez; John M Higgins; Vladislav Moltchanov; Frank C Kuo; Michael J Kluk; Brian Henderson; Leena Kinnunen; Heikki A Koistinen; Claes Ladenvall; Gad Getz; Adolfo Correa; Benjamin F Banahan; Stacey Gabriel; Sekar Kathiresan; Heather M Stringham; Mark I McCarthy; Michael Boehnke; Jaakko Tuomilehto; Christopher Haiman; Leif Groop; Gil Atzmon; James G Wilson; Donna Neuberg; David Altshuler; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

7.  Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.

Authors:  T L Kiss; H Chang; A Daly; H A Messner; N Jamal; D Spaner; S Rubin; J H Lipton
Journal:  Bone Marrow Transplant       Date:  2004-04       Impact factor: 5.483

8.  Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; Brent R Logan; Willis H Navarro; John E Levine; John P Miller; Bronwen E Shaw; Paul V O'Donnell; Navneet S Majhail; Dennis L Confer
Journal:  Blood       Date:  2014-04-15       Impact factor: 22.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.